|
In-Vitro Screening System Expressing Beta-Amyloid
|
Sayeeda Zain, PhD
Charles Marotta
|
|
Reactivity/Selectivity Methods For Calibrating Predictive Models for P450
|
Jeffrey Jones, PhD
LeeAnn Higgins, PhD
Kenneth Korzekwa
|
|
Use of Monobodies for Target Validation in Drug Discovery
|
Shohei Koide, PhD
|
|
Use of Molecular Techniques to Identify Regulators of Bone Formation
|
J. Edward Puzas, PhD (website)
|
|
Biliverdin Reductase is a Novel Cell Proliferation and Differentiation Factor
|
Mahin Maines, Ph.D.
|
|
Human Biliverdin Reductase is a New Member of the Insulin Receptor Substrate Family with Serine/Threonine/Tyrosine Kinase Activity
|
Mahin Maines, Ph.D.
|
|
Compositions and Methods for Treating Bone and Neuroinflammatory Diseases and Disorders
|
Stephanos Kyrkanides, D.D.S., Ph.D.
J. Edward Puzas, PhD (website)
|
|
RNA-Targeted Small Molecules as Potential Antiviral Therapy (HIV, SARS etc)
|
Benjamin Miller, Ph.D. (website)
Brian McNaughton
Peter Gareiss
Joseph Wedekind, Ph.D. (website)
|
|
A Rapid and Sensitive Method for the Toxicological Evaluation of Chemotherapeutic Agents and Environmental Toxicants, and for the Development of Protective Treatments of Such Toxicities
|
Mark Noble, PhD (website)
Chris Proschel, PhD (website)
Zaibo Li
Brett Stevens
Yin Miranda Yang
Tiefei Dong, PhD
|
|
Protein Kinase C-Associated Kinase PKK is Required for NF-kB Signaling and Survival in Diffuse Large-B Cell Lymphoma Cells
|
Luojing Chen, PhD
Jiyong Zhao, PhD (website)
|
|
SIRT1 and RelB as Targets for Treating Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
|
Irfan Rahman, Ph.D. (website)
|
|
A Novel Drug Target for Lupus Treatment
|
Luojing Chen, PhD
|
|
Oligocycloalkanoid Compounds and Methods of Use
|
Robert Hubbard
Benjamin Miller, Ph.D. (website)
|
|
Method of Determining Evolutionary Potential of Antibiotic Resistance Genes and Use to Screen for Drug Efficacy
|
Barry Hall
|
|
Drug Discovery for Age-Related Disease
|
David Goldfarb, Ph.D. (website)
Michael Breitenbach
|
|
Compounds that Prevent Age-Related Diseases by Evolutionary Conserved Mechanisms
|
David Goldfarb, Ph.D. (website)
|
